Genome study reveals human-to-human spread of multidrug resistant mycobacterial infection

March 28, 2013

Using DNA tracking of an outbreak among cystic fibrosis patients at a treatment centre in the UK, the scientists identified frequent patient-to-patient transmission despite stringent infection control measures.

The authors warn that the findings, published Online First in The Lancet, will have major implications for how patients with are cared for in hospitals and raise critical questions about the adequacy of current infection control measures and the potential for cross-infection in other .

Estimates suggest between 3% and 10% of individuals with cystic fibrosis in the USA and Europe are currently infected with multi-drug resistant M abscessus and numbers are rising. The organism causes progressive lung damage and is extremely difficult to treat.

Andres Floto from the University of Cambridge, Julian Parkhill from the Sanger Institute, and colleagues used whole genome sequencing and antimicrobial susceptibility testing to compare the of individual M abscessus isolates from 31 infected attending the Cambridge Centre for at Papworth Hospital between 2007 and 2011.

They also used social network analysis to compare opportunities for cross infection between patients carrying genetically clustered and unclustered cases, and environmental testing to exclude obvious potential sources of infection such as bronchoscopes and .

Findings showed that two clustered outbreaks were caused by genetically identical or near-identical strains of M abscessus subspecies massiliense (from 11 patients), that differed by less than ten .

"Isolates from these 11 patients were often more closely related to each other than to other samples from the same individual, strongly suggesting that cross-infection has occurred widely between patients", explains Floto.

What is more, he adds, "this group of patients had numerous opportunities for within-hospital transmission from other individuals, while widespread environmental sampling failed to detect any specific source of exposure to NTM infection."

The team further cemented their theory of cross-infection by demonstrating that the clusters of M abscessus subspecies massiliense had evidence of transmission of mutations acquired during infection of an individual to other patients, and isolated bacteria with resistance to amikacin and clarithromysin from several patients with no history of long-term use of these antibiotics.

"The increased resolution provided by over previous typing techniques allowed us to clearly identify the existence, and in some cases the direction, of patient-to-patient transmission, something that would not previously have been possible"*, says Parkhill.

According to Floto, "Despite our evidence of transmission of M abscessus subspecies massiliense between patients, the exact mechanism of cross-infection remains to be established. Because of strict infection control policies, we believe that transmission probably occurred indirectly, for example via fomite (eg, hair, clothing, and bedding) contamination or aerosol generating procedures such as lung function testing."

Explore further: Autophagy: When 'self-eating' is good for you

More information: Josephine M. Bryant, Dorothy M. Grogono, Daniel Greaves, Juliet Foweraker, Iain Roddick, Thomas Inns, Mark Reacher, Charles S. Haworth, Martin D. Curran, Simon R. Harris1, Sharon J. Peacock, Julian Parkhill1and R. Andres Floto. (2013) 'Evidence for transmission of Mycobacterium abscessus between Cystic Fibrosis patients from whole-genome sequencing. Published in the Lancet online 29 March 2013. doi: 10.1016/S0140-6736(13)60632-7 http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)60632-7/abstract

Related Stories

Autophagy: When 'self-eating' is good for you

April 4, 2012
(Medical Xpress) -- New discoveries by Cambridge scientists about a molecular waste-disposal process that ‘eats’ bacteria are influencing the clinical management of cystic fibrosis, and could be the basis of innovative ...

Microevolutionary analysis of Clostridium difficile genomes to investigate transmission

December 20, 2012
Over recent years, hospital-acquired Clostridium difficile infections have been a significant problem in UK hospitals and globally. There have been concerns that infections may be due to transmission between symptomatic patients, ...

U of T and SickKids first to grow lung cells using stem cell technology

August 29, 2012
Researchers at the University of Toronto and the Hospital for Sick Children (SickKids) are paving the way towards individualized medicine for patients with cystic fibrosis. 

Transmission of Clostridium difficile in hospitals may not be through contact with infected patients

February 7, 2012
Contrary to current convention by which infection with the organism Clostridium difficile is regarded as an infection that is acquired by contact with symptomatic patients known to be infected with C. difficile, these may ...

Recommended for you

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

Promising new target for treatment of psoriasis is safe, study shows

October 11, 2017
A protein known to play a significant role in the development of psoriasis can be prevented from functioning without posing a risk to patients, scientists at King's College London have found.

Norovirus evades immune system by hiding out in rare gut cells

October 11, 2017
Noroviruses are the leading cause of non-bacterial gastroenteritis in the world and are estimated to cause 267 million infections and 20,000 deaths each year. This virus causes severe diarrhea, nausea, and stomach pain.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.